Clinical protocols to monitor efficacy of [177Lu]Lu-PSMA radiopharmaceutical therapy in metastatic castration-resistant prostate cancer.

被引：0
|
作者：
Unterrainer, Lena [1 ]
De Leiris, Nicolas [2 ]
Unterrainer, Marcus [3 ]
Ilhan, Harun [4 ]
Delker, Astrid
Hempel, Linus
Ells, Zachary
Zahner, Joseph
Holzgreve, Adrien
Zacherl, Mathias J.
Casuscelli, Jozefina
Kiraz, Kevin
Leenhardt, Julien
Jacquet, Emmanuelle
Long, Jerome
Laramas, Mathieu
Paller, Channing Judith
Solnes, Lilja B.
Gafita, Andrei
Djaileb, Loic
机构：
[1] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Nucl Med, Munich, Germany
[2] CHU Grenoble Alpes, Grenoble, France
[3] Ludwig Maximilians Univ Munchen, Dept Radiol, Munich, Germany
[4] Ludwig Maximilians Univ Munchen, Munich, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 5_SUPPL期
关键词：
D O I：
10.1200/JCO.2025.43.5_suppl.39
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：39 / 39
页数：1
相关论文
共 50 条
  • [21] High Activity 177Lu-PSMA Therapy Of Metastatic Castration-resistant Prostate Cancer
    Happel, C.
    Kranert, W. T.
    Bockisch, B.
    Groener, D.
    Davis, K. H.
    Wichert, J.
    Stefanova, M.
    Gruenwald, F.
    Sabet, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S647 - S648
  • [22] Early biochemical and radiographic response after one cycle of [177Lu]Lu-PSMA I&T radioligand therapy in metastatic castration-resistant prostate cancer patients
    Wojciech Cytawa
    Robin Hendel
    Bartłomiej Tomasik
    Franz-Xaver Weinzierl
    Thorsten Bley
    Jacek Jassem
    Andreas Schirbel
    Andreas K. Buck
    Ralph A. Bundschuh
    Philipp E. Hartrampf
    Rudolf A. Werner
    Constantin Lapa
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 3765 - 3776
  • [23] Early biochemical and radiographic response after one cycle of [177Lu]Lu-PSMA I&T radioligand therapy in metastatic castration-resistant prostate cancer patients
    Cytawa, Wojciech
    Hendel, Robin
    Tomasik, Bartlomiej
    Weinzierl, Franz-Xaver
    Bley, Thorsten
    Jassem, Jacek
    Schirbel, Andreas
    Buck, Andreas K.
    Bundschuh, Ralph A.
    Hartrampf, Philipp E.
    Werner, Rudolf A.
    Lapa, Constantin
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (12) : 3765 - 3776
  • [24] Extended therapy with [177Lu]Lu-PSMA-617 in responding patients with high-volume metastatic castration-resistant prostate cancer
    Mader, Nicolai
    Ngoc, Christina Nguyen
    Kirkgoeze, Bilge
    Baumgarten, Justus
    Groener, Daniel
    Klimek, Konrad
    Happel, Christian
    Tselis, Nikolaos
    Chun, Felix K. H.
    Gruenwald, Frank
    Sabet, Amir
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (06) : 1811 - 1821
  • [25] Extended therapy with [177Lu]Lu-PSMA-617 in responding patients with high-volume metastatic castration-resistant prostate cancer
    Nicolai Mader
    Christina Nguyen Ngoc
    Bilge Kirkgöze
    Justus Baumgarten
    Daniel Groener
    Konrad Klimek
    Christian Happel
    Nikolaos Tselis
    Felix K. H. Chun
    Frank Grünwald
    Amir Sabet
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 1811 - 1821
  • [26] Predictors of overall survival in metastatic castration-resistant prostate cancer patients receiving [177Lu]Lu-PSMA-617 radioligand therapy
    Ahmadzadehfar, Hojjat
    Schlolaut, Stephan
    Fimmers, Rolf
    Yordanova, Anna
    Hirzebruch, Stefan
    Schlenkhoff, Carl
    Gaertner, Florian C.
    Awang, Zool Hilmi
    Hauser, Stefan
    Essler, Markus
    ONCOTARGET, 2017, 8 (61) : 103108 - 103116
  • [27] Dual Radionuclide Therapy: The Synergistic Effects of [161Tb]Tb-PSMA and [177Lu]Lu-PSMA in Advanced Prostate Cancer Post [177Lu]Lu-PSMA Failure
    Abdlkadir, Ahmed Saad
    Abufara, Alaa
    Al-Ibraheem, Akram
    NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 58 (06) : 381 - 382
  • [28] COST-EFFECTIVENESS OF [177LU]LU-PSMA-617 IN PROGRESSIVE PSMA-POSITIVE METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
    Brockbank, J.
    Hancock, H.
    Khare, A.
    Joshi, P.
    Risson, V
    VALUE IN HEALTH, 2024, 27 (12) : S121 - S121
  • [29] Dosimetric Analysis of a Phase I Study of PSMA-Targeting Radiopharmaceutical Therapy With [177Lu]Ludotadipep in Patients With Metastatic Castration-Resistant Prostate Cancer
    Ha, Seunggyun
    Hyun, O. Joo
    Park, Chansoo
    Boo, Sun Ha
    Yoo, Ie Ryung
    Moon, Hyong Woo
    Chi, Dae Yoon
    Lee, Ji Youl
    KOREAN JOURNAL OF RADIOLOGY, 2024, 25 (02) : 179 - 188
  • [30] Biodistribution and dosimetry of [177Lu]Lu-SibuDAB in patients with metastatic castration-resistant prostate cancer
    Ritt, Philipp
    Nicolai, Heinz
    Fernandez, Rene
    Soza-Ried, Cristian
    Amaral, Horacio
    Krieger, Korbinian
    Mapanao, Ana Katrina
    Rotger, Amanda
    Zhernosekov, Konstantin
    Schibli, Roger
    Mueller, Cristina
    Kramer, Vasko
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025,
12345